Validation of the Inflammatory Bowel Disease Disability Index in a population-based cohort-Reference-Cited by-同舟云学术

Validation of the Inflammatory Bowel Disease Disability Index in a population-based cohort

Published:2015-12-08 Issue:4 Volume:66 Page:588-596
ISSN:0017-5749
Container-title:Gut
language:en
Short-container-title:Gut

Author:

Gower-Rousseau Corinne,Sarter Hélène,Savoye Guillaume,Tavernier Noémie,Fumery Mathurin,Sandborn William J,Feagan Brian G,Duhamel Alain,Guillon-Dellac Nathalie,Colombel Jean-Frédéric,Peyrin-Biroulet Laurent

Publisher

BMJ

Subject

Gastroenterology

Reference36 articles.

1. Impact of inflammatory bowel disease on health-related quality of life;Casellas;Dig Dis,1999

2. What is the patient's perspective: How important are patient-reported outcomes, quality of life and disability?;Peyrin-Biroulet;Dig Dis,2010

3. Disability in inflammatory bowel diseases: developing ICF Core Sets for patients with inflammatory bowel diseases based on the International Classification of Functioning, Disability, and Health;Peyrin-Biroulet;Inflamm Bowel Dis,2010

4. Patient-reported outcomes as primary end points in clinical trials of inflammatory bowel disease;Williet;Clin Gastroenterol Hepatol,2014

5. Converging goals of treatment of inflammatory bowel disease from clinical trials and practice;Levesque;Gastroenterology,2015

Cited by 121 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Deficits in geriatric assessment are important in relation to fatigue in older patients with Inflammatory Bowel Disease;Digestive and Liver Disease;2024-09

2. Introducing the Arabic inflammatory bowel disease disk as a tool for assessing disability in patients with inflammatory bowel disease in Jordan;Arab Journal of Gastroenterology;2024-09

3. Mirikizumab Sustained Impact on Fatigue in Patients with Moderately to Severely Active Crohn’s Disease in the Phase 2 AMAG Study;Inflammatory Bowel Diseases;2024-08-02

4. Navigating the complexities of drug development for inflammatory bowel disease;Nature Reviews Drug Discovery;2024-05-22

5. Changes Over Time in the Lémann Index and the Inflammatory Bowel Disease Disability Index in a Prospective Cohort of Patients With Crohn’s Disease;Inflammatory Bowel Diseases;2024-04-10